Recent studies have elaborated on the anti‐cancer mechanisms of cannabinoids beyond endocannabinoid signaling via the CB1/CB2 receptor, including ferroptosis induction, mitochondrial dysfunction, integrated stress response activation, and epigenetic modulation. This evidence concerns the gene CNR1 and cancer.